NEW: Online Open - articles free to readers on publication for an author fee

Fundamental & Clinical Pharmacology

Published on behalf of the Société Française de Pharmacologie et de Thérapeutique and the Federation of the European Pharmacological Societies (EPHAR), and officially affiliated to the ESC Working Group on Cardiovascular Pharmacology and Drug Therapy

Edited by:
Pascal Bousquet and Faiez Zannad

ISI Journal Citation Reports® Ranking: 2007: 101/205 (Pharmacology & Pharmacy)
Impact Factor: 2.129

---

Published on behalf of the Société Française de Pharmacologie et de Thérapeutique and of the Federation of the European Pharmacological Societies (EPHAR), Fundamental & Clinical Pharmacology publishes reports describing important and novel developments in fundamental as well as clinical research relevant to drug therapy.

Original articles, short communications and reviews are published on all aspects of experimental and clinical pharmacology. Clinical research, including clinical studies and clinical trials, may cover disciplines such as pharmacokinetics, pharmacodynamics, pharmacovigilance, pharmacoepidemiology, pharmacogenomics and pharmacoeconomics. Basic research articles from fields such as physiology and molecular biology which contribute to an understanding of drug therapy are also welcomed.

TopNews and Announcements

Abstracts of the EPHAR 2008 Congress, Manchester, UK, 13-17 July 2008

Click here for FREE access!

 

Virtual Issue
Editors' Choice in Cardiovascular Pharmacology April 2008
Click here for FREE access!

 

FCP welcomes the ESC Working Group on Cardiovascular Pharmacology and Drug Therapy

FCP is extremely pleased to announce that as of October 2007 the journal is officially affiliated to the ESC Working Group on Cardiovascular Pharmacology and Drug Therapy. Click here to view the editorial from the October issue.

 

Articles published online ahead of print in EarlyView
Articles which have been fully copy-edited and peer-reviewed are published online before the print edition of this journal is published. Click here to access.

Free access to some of the top-cited articles from 19/20

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
Michael Schachter (19:1)

G protein-coupled receptors: a count of 1001 conformations
G. Vauquelin, I. Van Liefde (19:1)

Herb-drug interactions: an overview of the clinical evidence
Angelo A. Izzo (19:1)

Allergy-like reactions to iodinated contrast agents. A critical analysis
Jean-Marc Idée, Emmanuelle Pinès, Philippe Prigent, Claire Corot (19:3)

Eradication of Helicobacter pylori: recent advances in treatment
Ramona M. McLoughlin, Colm A. O'Morain, Humphrey J. O'Connor (19:4)

Adenosine receptors: promising targets for the development of novel therapeutics and diagnostics for asthma
Cristina Russo, Giuseppe Arcidiacono, Riccardo Polosa (20:1)

Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect
Mustafa Büyükavcý, Öner Özdemir, Steven Buck, Mark Stout, Yaddanapudi Ravindranath, Süreyya Savaþan (20:1)

Clinical methods for the evaluation of endothelial function - a focus on resistance arteries
Robinson Joannides, Jeremy Bellien, Christian Thuillez (20:3)

Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance
Estelle Weinling, Stuart McDougall, Frédéric Andre, Gabrio Bianchetti, Catherine Dubruc (20:4)

Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review
Jean-Marc Idée, Marc Port, Isabelle Raynal, Michel Schaefer, Soizic Le Greneur, Claire Corot (20:6)

NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate,  please visit our policy statement.